Monthly Update: Biologicals & Immunologicals: The autoimmunity of cancer as applied to drug development

References

• TEILLAUD J-L, DESAYMARD C, GUISTI AM, HASELTINE B, POLLOCK RR, YELTON DE, ZACK DJ, SCHARFF MD: Mono-clonal antibodies reveal the structural basis of antibody diversity. Science (1983) 222:721–736.
   PubMed Web of Science ®Google Scholar
• GLASSY MC, MCKNIGHT ME: A novel drug discovery programme utilizing the human immune response. Cum. Opin. Invest. Drugs (1993) 2:853–858.
   Google Scholar
• GLASSY MC, MCKNIGHT ME: Pharming the human lymph node. Exp. Opin. Invest. Drugs (1994) 3:1057–1060.
   Google Scholar
• GLASSY MC, MCKNIGHT ME: The rate-limiting step in obtaining human monoclonal antibody drug pharma-ceuticals. Exp. Opin. Invest. Drugs (1995) 4:225–228.
   Google Scholar
• KODA K, GLASSY MC: In vitro immunization for the production of human monoclonal antibodies. Human Antibod. Hybrldomas (1990) 1:15–22.
   PubMedGoogle Scholar
• BORREBAECK CAK, DANIELSSON L, MOLLER SA: Human monoclonal antibodies produced by primary in vitro Immunization of peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA (1988) 85:3995–3999.
   PubMed Web of Science ®Google Scholar
• JAMES K, BELL GT: Human monoclonal antibody pro-duction. Current status and future prospects. J. Immu-nol. Meth. (1987) 100:5–40.
   PubMed Web of Science ®Google Scholar
• NAPARSTEK Y, PLOTZ PH: The role of autoantibodies inautoimmune disease. Ann. Rev. Immunol. (1993) 11:79–104.
   PubMed Web of Science ®Google Scholar
• BARI3AS C, DITZEL HJ, SALONEN EM, YANG WP, SILVER-MAN GJ, BURTON DR: Human autoantibody recognition of DNA_ Proc. Natl. Acad. Sci. USA (1995) 92:2529–2533.
   PubMed Web of Science ®Google Scholar
• RONDA N, HAURYM, NOBREGA A, KAVER SV, COUTINHOA, KAZATCHKINE MD: Analysis of natural and disease-associated autoantibody repertoires: anti-endothelial cell IgG autoantibody activity in the serum of healthy Individuals and patients with systemic lupus erythema-tosis. Intl. Immunol. (1994) 6:1651–1660.
   PubMed Web of Science ®Google Scholar
• GLASSY MC: Production methods for generating humanmonoclonal antibodies. Human Antibod. Hybridomas (1993) 4:154–165.
   PubMedGoogle Scholar
• FREEMAN JW, BUSCH H: Monoclonal antibodies to hu-man tumor nucleolar antigens: probes for studying biological function and determining clinical signifi-cance. Human Antibod. Hybridomas (1991) 2:4–10.
   PubMedGoogle Scholar
• SCIELOM J, WUNDERLICH D, TERAMOTO YA: Generationof human monoclonal antibodies reactive with human mammary carcinoma cells. Proc. Natl. Acad. Sci. USA (1980) 77:6841–6845.
   PubMed Web of Science ®Google Scholar
• HOUGHTEN AN, BROOKS H, COTE RJ, TAROMINA JC,OETrGEN MC, OLD LK: Detection of cell surface and intracellular antigens by human monoclonal antibod-ies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma. J. Exp. Med. (1983) 158:53–65.
   Google Scholar
• GLASSY MC, HANDLEY HH, HAGIWARA H, ROYSTON I:UC 729-6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybrido-mas. Proc. Natl. Acad. Sci. USA (1983) 80:6327–6331.
   PubMed Web of Science ®Google Scholar
• HASPEL MV, MCCABE RP, POMATO N, JANESCH NJ, KNOWLTON JV, PETERS LC, HOOVER HC, HANNA MG: Generation of tumour cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients. Can-cer Res. (1985) 45:3951–3961.
   PubMed Web of Science ®Google Scholar
• KAN-MITCHELL J, IMAM A, KEMPF RA, TAYLOR CR, MITCHELL MS: Human monoclonal antibodies directed against melanoma tumour-associated antigens. Cancer Res. (1986) 46:2490–2496.
   PubMed Web of Science ®Google Scholar
• GLASSY MC: Immortalization of human lymphocytesfrom a tumour involved lymph node. Cancer Res. (1987) 47:5181–5188.
   PubMed Web of Science ®Google Scholar
• LARRICK J, FRY RE: Recombinant antibodies. Human Antibod. Hybridomas (1991) 2:172–189.
   PubMedGoogle Scholar
• WINTER G, MILSTEIN C: Man-made antibodies. Nature (1991) 349:293–299.
   PubMed Web of Science ®Google Scholar
• KODA K, GLASSY MC, CHANG HR: Generation of human monoclonal antibodies against colon cancer. Arch. Sur g. (1990) 125:1591–1597.
   PubMed Web of Science ®Google Scholar
• CHANG HR, KODA K, CHANG S, BAIRD S: AgSK1, a novelcarcinoma associated antigen. Cancer Res. (1993) 53:1122–1127.
   PubMed Web of Science ®Google Scholar
• CHANG HR, CHAVOSHAN B, PARK H: Human mono-clonal antibody SK1-mediated cytotoxicity against co-lon cancer cells. Dis. Colon Rectum (1993) 36:1152–1157.
   PubMed Web of Science ®Google Scholar
• CHANG HR, KODAK, MCKNIGHT ME, GLASSY MC: Tumor-associated antigens recognised by human monoclonal antibodies. Ann. Stag. (1994) 1:221–231.
   Google Scholar
• GLASSY MC: Generation of UC 729-6 and SHFP-1 derivedhuman hybridomas and their growth in serum-free media. J Tissue Culture Meth. (1989) 12:85–89.
   Google Scholar
• KOHLER G, MILSTEIN C: Continuous cultures of fusedcells secreting antibody of predefined specificity. Na-ture (1975) 256:495–497.
   PubMed Web of Science ®Google Scholar
• TENG NNH, KAPLAN HS, HERBERT JM, MOORE C, DOUGLAS H, WUNDERLICH A, BRAUDE AJ: Protection against Gram-negative bacteremia and endotoxinemia with human monoclonal IgM antibodies. Proc. Natl. Acad. Scl. USA (1985).
   Google Scholar
• ZIEGLER EJ, FISCHER CJ, SPRUNG CL, STRAUBE RC, SADOFF JC, FOULKE GE, WORTEL CH, FINK MP, DELLIN- GER RP, TENG NNH, ALLEN IE, BERGER HJ, KNAIIERUDGL, LOBUGLIO AF, SMITH CR: Treatment of Gram-nega-tive bacteresnia and septic shock with HA-1A human monoclonal antibody against endotoxin. New Engl. J. Med. (1991) 324:429–436.
   PubMed Web of Science ®Google Scholar
• SHOENFELD Y, HSU-UN SC, GABRIELS JE, SILBERSTEIN LE,FURIE BC, FURIE B, STOLLAR BD, SCHWARTZ RS: Produc-tion of autoantibodies by human-human hybridornas. J. din. Invest. (1982) 70:205–208.
   PubMed Web of Science ®Google Scholar